STAT3 and familial pancreatic carcinoma: Additionally, STAT3 hyperactivation has been implicated in cancer progression and poor prognosis in pancreatic cancer [53,54], prostate cancer [55], colorectal cancer [56], and esophageal cancer [57,58].